Am­gen con­tin­ues to tar­get mid-De­cem­ber dead­line for Hori­zon deal close

Am­gen and Hori­zon con­tin­ue to tar­get a mid-De­cem­ber close for their $28 bil­lion merg­er, though a court or­der tem­porar­i­ly block­ing the deal has been ex­tend­ed …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER